Effects of the SGLT2 Inhibitor Dapagliflozin on Cardiac Function Evaluated by Impedance Cardiography in Patients With Type 2 Diabetes. Secondary Analysis of a Randomized Placebo-Controlled Trial

Cardiovascular Diabetology - United Kingdom
doi 10.1186/s12933-019-0910-5